Tahla Munir News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The latest drugs for chronic lymphocytic leukemia (CLL) offer prolonged remission, along with a need for better tools to gauge their effectiveness: measurable residual disease (MRD) could be useful.

United statesKamelia fisherAlessandra ferrajoliUniversity of leedsUniversity of texas md anderson cancer centerTahla munirTeaching hospitalsNational health serviceCancer centerChronic lymphocytic leukemiaGenomic medicineEdicine genomicHealthcare and medical technologyEalth and medical techEalth and med techEalth and medical technology